Leaders in Health Economics and Outcomes Research Convened to Focus on Improving Healthcare Systems

Published Nov 15, 2018

ISPOR Europe 2018 Drew the Society’s Largest Audience To Date With More Than 5000 Healthcare Stakeholders in Barcelona, Spain

Barcelona, Spain—November 15, 2018—ISPOR Europe 2018 concluded yesterday in Barcelona, Spain with record attendance. The Society had 5507 total attendees register for the event—the largest for any of its conferences to date. ISPOR Europe is organized by ISPOR—the professional society for health economics and outcomes research (HEOR)—and is the leading HEOR conference in the region. ISPOR Europe 2018 attendees include a wide variety of healthcare stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, and patient engagement organizations. The conference theme centered on “New Perspectives for Improving 21st Century Health Systems.” Program co-chairs included Sarah Garner, PhD, World Health Organization, Switzerland; Zoltán Kaló, PhD, Eötvös Loránd University, Hungary; and Guillem López-Casasnovas, PhD, Universitat Pompeu Fabra, Spain. Highlights from the ISPOR Europe 2018 program included: Plenary 1: Joint Assessment of Relative Effectiveness: ‘Trick or Treat’ for Decision Makers in EU Member States”This session was held on Monday, 12 November 2018 and the panel discussed the European Commission’s draft regulation on health technology assessment (HTA) that proposes the introduction of a Europe-wide joint clinical assessment. Plenary 2:Pharmaceutical Pricing: The Many Faces of FairnessThis session was held on Tuesday, 13 November 2018 with the panel focused on defining “fair” in the context of pharmaceutical pricing in the context of the World Health Organization’s first Fair Pricing Forum held in 2017. Plenary 3: Budget Impact and Expenditure Caps: Potential or Pitfall? This session was held Wednesday, 14 November 2018 and featured discussions on the benefits and challenges of controlling the budget impact of health policies by implementing financial caps in Europe. ISPOR Europe 2018 also featured sessions on artificial intelligence in healthcare, creating the “next” healthcare system, medical devices and European Union policy, pricing approaches and universal health coverage, how patient engagement is transforming healthcare, how a healthcare “cure” can be valued, ISPOR’s HEOR Competencies Framework™, and challenges to open science in HEOR. A number of awards were presented at the conference, including the Society’s Outstanding Chapter Awards. The conference also featured the Society’s renowned Essential HEOR Education curriculum of half- and full-day short courses on 10-11 November 2018. “HEOR has never been more important and the fact that ISPOR Europe 2018 drew the Society’s largest audience to date speaks to the significance of our members’ work,” stated ISPOR CEO Nancy S. Berg. “This conference focused on convening world leaders in health economics and outcomes research to discuss how to best improve health systems globally. ISPOR is honored to provide a forum for these important discussions and to play a role in improving healthcare decisions globally.” Additional information on ISPOR Europe 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBarcelona.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×